Fralick Michael, Avorn Jerry, Kesselheim Aaron S
From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (M.F., J.A., A.S.K.); and the University of Toronto Clinician-Scientist Training Program, Toronto (M.F.).
N Engl J Med. 2017 Jul 27;377(4):311-313. doi: 10.1056/NEJMp1704489.